SURPASS-2 Trial: Tirzepatide (Mounjaro) versus Semaglutide (Ozempic) for diabetes SURPASS-2 Trial: Tirzepatide vs Semaglutide (Ozempic) Summary: Tirzepatide was superior to semaglutide for both diabetic control and weight loss
Tier 3 (BMI 35-39.9 with comorbidities or BMI 40+): Aggressive pharmacotherapy with GLP-1 agonists or dual agonists, potentially combined with very low-calorie dietary interventions and consideration of bariatric surgery referral if medical management is insufficient
I offer online nutrition counseling through Healthful focused on everyday eating, cultural food traditions, and realistic routines
Non-alcoholic fatty liver disease (NAFLD) is a common condition characterised by excessive fat accumulation in the liver of individuals who consume little to no alcohol (typically defined as less than 14 units per week in the UK)
Excitotoxicity and Epilepsy Glutamate-induced excitotoxicity is a hallmark of various neurological conditions, including strokes, neurodegenerative diseases, and epilepsy (Nicolo, OBrien & Kwan, 2019)
Pregnant women, vegans, individuals with certain food allergies, those with lactose intolerance, and others who consume little or no dairy, fish, or iodized salt may be at risk of inadequate iodine intake